ACS partners
To promote cardiovascular research in the Netherlands and stimulate collaboration, ACS researchers participate in several joint networks.
Rembrandt Institute of Cardiovascular Science
Cardiovascular research groups from LUMC, Amsterdam UMC and Sanquin organize a joint annual research meeting. Rembrandt grants support joint research projects between the participating centers. Website RICS
Netherlands Heart Institute
NLHI provides a network for cardiology and cardiovascular research departments to promote and facilitate research at a national level. The NLHI Durrer Center supports centralization of biobanking and cardiogenetics. The NLHI cooperates closely with the Netherlands Heart Foundation and is a partner of the Dutch CardioVascular Alliance (DCVA). Website NLHI
Affiliated societies
Dutch Heart Foundation
The Dutch Heart Foundation (DHF) is a Dutch non-profit organization that is committed to recognize, detect and treat cardiovascular diseases in an early stage and to reduce the burden of disease. Website DHF
European Society of Cardiology
The European Society of Cardiology (ESC) is a not-for-profit medical society. They unite national cardiac societies from around the world to understand the impact of cardiovascular disease and to reduce the burden of disease. Website ESC
Nederlandse Vereniging voor Cardiologie
The 'Nederlandse Vereniging voor Cardiologie (NVVC)' unites cardiologists, nursing specialists and physician assistants in the Netherlands. Website NVVC
Dutch CardioVascular Alliance
The Dutch CardioVascular Alliance (DCVA) is an alliance of twelve organizations, scientists and healthcare professionals in the field of cardiovascular research. The common goal is to reduce the disease burden by a quarter by 2030. Website DCVA
Research consortia
Some of the research consortia ACS is involved in are:
Institute for human Organ and Disease Model technologies
The Institute for human Organ and Disease Model technologies (hDMT) is a precompetitive non-profit technological R&D institute, initiated in the Netherlands. hDMT integrates state-of-the-art human stem cell technologies with top level engineering, physics, chemistry, biology, clinical and pharmaceutical expertise from academia and industry to develop and valorize human organ and disease models-on-a-chip. Website hDMT
Atrial Fibrillation Innovation Platform
The Atrial Fibrillation Innovation Platform (AFIP) Foundation consists of a team of researchers and doctors who want to improve communication between patients and researchers in the field of atrial fibrillation. Website AFIP